15 Jul 2024
// PRESS RELEASE
24 Jun 2024
// PRESS RELEASE
10 May 2024
// PRESS RELEASE
Latest Content by PharmaCompass
KEY SERVICES
Reset all filters
01 2ACITRETIN
02 4ADALIMUMAB
03 3ATOGEPANT
04 1BERACTANT
05 1BEZAFIBRATE
06 2BIMATOPROST
07 3BRIMONIDINE TARTRATE
08 1CARBIDOPA (CARBIDOPA MONOHYDRATE)
09 8CARBOXYMETHYLCELLULOSE SODIUM
10 4CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE)
11 2CYCLOSPORINE
12 1DEOXYCHOLIC ACID
13 1DEXAMETHASONE
14 2ELAGOLIX (ELAGOLIX SODIUM)
15 2ELUXADOLINE
16 2EPCORITAMAB
17 2ETHINYL ESTRADIOL
18 1FLUOROMETHOLONE
19 1FOSCARBIDOPA
20 1FOSLEVODOPA
21 1GATIFLOXACIN
22 2GLECAPREVIR
23 3GLYCERINE
24 2KETOROLAC TROMETHAMINE
25 5LEUPROLIDE ACETATE
26 1LEVODOPA
27 4LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
28 3LINACLOTIDE
29 3LOPINAVIR
30 5MESALAZINE
31 1MINERAL OIL
32 1MIRVETUXIMAB SORAVTANSINE
33 1NAPHAZOLINE HYDROCHLORIDE
34 4NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
35 1NORETHINDRONE ACETATE
36 1OFLOXACIN
37 4ONABOTULINUMTOXINA
38 2PIBRENTASVIR
39 1POLYSORBATE 80
40 1POLYVINYL ALCOHOL
41 1PREDNISOLONE ACETATE
42 5RISANKIZUMAB
43 3RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
44 4RITONAVIR
45 1SEVOFLURANE
46 2SUCRALFATE
47 1TIMOLOL (TIMOLOL MALEATE)
48 2UBROGEPANT
49 3UPADACITINIB
50 6VENETOCLAX
51 3VILAZODONE HYDROCHLORIDE
52 1WHITE PETROLATUM
Reset all filters
01 9CAPSULE
02 4CAPSULE (EXTENDED RELEASE)
03 5DROPS
04 2EMULSION
05 2GEL
06 2GRANULES
07 1IMPLANT
08 3KIT
09 1LIQUID
10 2OINTMENT
11 4POWDER FOR SOLUTION
12 5POWDER FOR SUSPENSION, SUSTAINED-RELEASE
13 36SOLUTION
14 2SUPPOSITORY
15 6SUSPENSION
16 32TABLET
17 2TABLET (DELAYED-RELEASE)
18 4TABLET (EXTENDED-RELEASE)
Reset all filters
01 10.01%/W/V
02 10.03%/W/V
03 20.05%/W/V
04 20.1%/W/V
05 10.15%/W/V
06 20.2%/W/V
07 20.3%/W/V
08 10.45%/W/V
09 20.5%
10 60.5%/W/V
11 10.7MG
12 20.9%/W/V
13 11%
14 41%/W/V
15 11.4%/W/V
16 11.5MG
17 11000MG
18 7100MG
19 1100MG/20ML
20 1100MG/5ML
21 2100UNIT/VIAL
22 210MCG
23 610MG
24 110MG/ML
25 111.25MG/SYR
26 1120MG
27 112MG/ML
28 1145MCG
29 2150MG
30 2150MG/1ML
31 115MG
32 1180MG/1.2ML
33 11G
34 11G/5ML
35 11MG
36 12.5MG
37 2200MG
38 1200UNIT/VIAL
39 320MG
40 120MG/0.2ML
41 120MG/ML
42 120MG/SACHET
43 122.5MG/SYR
44 1240MG/ML
45 225MG
46 125MG/ML
47 1290MCG
48 12G/60G
49 13.75MG/SYR
50 230MG
51 130MG/SYR
52 235MG
53 1360MG/2.4ML
54 13MG
55 14.5MG
56 1400MG
57 1400MG/5ML
58 340MG
59 240MG/0.4ML
60 140MG/0.8ML
61 142.5%
62 145MG
63 14G/60G
64 2500MG
65 450MG
66 150MG/SACHET
67 150UNIT/VIAL
68 157.3%
69 15MG
70 25MG/ML
71 160MG
72 260MG/ML
73 16MG
74 17.5MG/SYR
75 172MCG
76 175MG
77 180MG
78 199.97%
Reset all filters
01 2ACTONEL
02 1ACTONEL DR
03 1ACULAR
04 1ACUVAIL
05 1ALBALON
06 1ALPHAGAN
07 1ALPHAGAN P
08 1BELKYRA
09 1BEZALIP SR
10 3BOTOX
11 1BOTOX COSMETIC
12 4BYSTOLIC
13 2COMBIGAN
14 3CONSTELLA
15 2DUODOPA
16 1ELAHERE
17 2EPKINLY
18 4FETZIMA
19 1FML
20 4HUMIRA
21 6KALETRA
22 1LATISSE
23 3LOLO
24 1LUMIGAN RC
25 5LUPRON DEPOT
26 4MAVIRET
27 1NORVIR
28 1OCUFLOX
29 2ORILISSA
30 1OZURDEX
31 1PRED FORTE
32 3QULIPTA
33 1REFRESH
34 1REFRESH CELLUVISC
35 1REFRESH CONTACTS
36 2REFRESH LACRI-LUBE
37 1REFRESH LIQUIGEL
38 3REFRESH OPTIVE ADVANCED
39 2REFRESH OPTIVE FUSION
40 2REFRESH OPTIVE GEL DROPS
41 1REFRESH PLUS
42 1REFRESH TEARS
43 1RESTASIS
44 1RESTASIS MULTIDOSE
45 3RINVOQ
46 5SALOFALK
47 1SEVORANE AF
48 5SKYRIZI
49 2SORIATANE
50 1SULCRATE
51 1SULCRATE SUSPENSION PLUS
52 1SURVANTA
53 2UBRELVY
54 6VENCLEXTA
55 2VIBERZI
56 3VIIBRYD
57 4VRAYLAR
58 2VYALEV
59 1ZYMAR
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SUSPENSION
Dosage Strength : 25MG/ML
Packaging : 4ML/8ML
Brand Name : SURVANTA
Approval Date :
Application Number : 2016109
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070863
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 10MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070847
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.8ML
Packaging :
Brand Name : HUMIRA
Approval Date :
Application Number : 2258595
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.4ML
Packaging : 0.4ML
Brand Name : HUMIRA
Approval Date :
Application Number : 2458357
Regulatory Info : Schedule D
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 40MG/0.4ML
Packaging :
Brand Name : HUMIRA
Approval Date :
Application Number : 2458349
Regulatory Info : Schedule D
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 20MG/0.2ML
Packaging : 0.2ML
Brand Name : HUMIRA
Approval Date :
Application Number : 2474263
Regulatory Info : Schedule D
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533979
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533987
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 60MG
Packaging :
Brand Name : QULIPTA
Approval Date :
Application Number : 2533995
Regulatory Info : Prescription
Registration Country : Canada